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ABSTRACT
Background: Stimulation of various sites, from the nasal mucosa to the dia-
phragm, can evoke laryngospasm. To reduce airway reflexes, tracheal extubation 
should be performed while the patient is deeply anesthetized or with drugs that do 
not depress ventilation. However, tracheal extubation during rhinoplasty may be dif-
ficult because of the aspiration of blood and the possibility of laryngospasm. Dexmede- 
tomidine and fentanyl both have sedative and analgesic effects, but dexmedetomidine 
has been reported to induce sedation without affecting respiratory status.
Objective: The aim of this study was to compare the effects of dexmedetomi-
dine and fentanyl on airway reflexes and hemodynamic responses to tracheal extuba-
tion in patients undergoing rhinoplasty.
Methods: This double-blind, randomized, controlled study was conducted at 
the Erciyes University Medical Center, Kayseri, Turkey. Patients classified as Ameri-
can Society of Anesthesiologists physical status I or II who were undergoing elective 
rhinoplasty between January 2007 and June 2007 with general anesthesia were eli-
gible for study entry. Using a sealed-envelope method, the patients were randomly 
divided into 2 groups (20 patients per group). Five minutes before extubation, pa-
tients received either dexmedetomidine 0.5 μg/kg in 100 mL of isotonic saline or 
fentanyl 1 μg/kg in 100 mL of isotonic saline intravenously. All patients were extu-
bated by anesthesiologists who were blinded to the study drugs, and all were continu-
ously monitored for 15 minutes after extubation. Heart rate (HR), systolic blood 
pressure (SBP), diastolic blood pressure (DBP), and oxygen saturation using pulse 
oximetry (SpO2) were recorded before anesthesia, after drug administration, after skin 
incision, at the completion of surgery, and 1, 5, and 10 minutes before and after tra-
cheal extubation. Any prevalence of laryngospasm, bronchospasm, or desaturation was 
recorded.
Results: Forty patients (25 men, 15 women; mean [SD] age, 24.86 [7.43] years) 
were included in the study. Dexmedetomidine was associated with a significant 
increase in extubation quality compared with fentanyl, reflected in the prevalence of 
cough after extubation (85% [17/20] vs 30% [6/20] of patients, respectively; P = 
˘
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0.001). There were no clinically significant decreases in HR, SBP, DBP, or SpO2 after 
extubation with dexmedetomidine or fentanyl. In the dexmedetomidine group, HR 
was not significantly increased after extubation; however, in the fentanyl group, HR 
was significantly increased compared with the preextubation values (all, P = 0.007). 
HR was significantly higher in the fentanyl group compared with the dexmedetomi-
dine group at 1, 5, and 10 minutes after extubation (all, P = 0.003). Compared with 
preextubation values, SBP was significantly increased at 1 and 5 minutes after extuba-
tion in the dexmedetomidine group (both, P = 0.033) and at 1, 5, and 10 minutes 
after extubation in the fentanyl group (all, P = 0.033). The postoperative sedation 
scores and the extubation, awakening, and orientation times were not signifi-
cantly different between the 2 groups. In the dexmedetomidine group, bradycardia 
(HR <45 beats/min) was observed in 2 patients and emesis was observed in 2 patients. 
In the fentanyl group, emesis was observed in 3 patients, bradycardia in 2 patients, 
vomiting in 1 patient, and shivering in 1 patient; vertigo was reported in 1 patient. 
There were no significant differences in the prevalence of adverse events between the 
2 groups.
Conclusion: The findings in the present study suggest that dexmedetomidine 
0.5 μg/kg IV, administered before extubation, was more effective in attenuating air-
way reflex responses to tracheal extubation and maintaining hemodynamic stability 
without prolonging recovery compared with fentanyl 1 μg/kg IV in these patients 
undergoing rhinoplasty. (Curr Ther Res Clin Exp. 2009;70:209–220) © 2009 Excerpta 
Medica Inc.
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INTRODUCTION
When a patient is deeply anesthetized, tracheal extubation during rhinoplasty can be 
difficult because of an obstructed nasal airway, blood and secretions in the pharynx, 
and difficulty performing manual ventilation by face mask owing to the newly recon-
structed nose.1 However, when a patient is lightly anesthetized, extubation can stimu-
late reflex responses via tracheal and laryngeal irritation.2 Complications of extubation 
(eg, bucking [gagging caused by involuntarily resisting positive pressure ventilation 
in a patient with an endotracheal tube in place], breath holding, laryngospasm, pul-
monary edema) might occur.3 Laryngospasm is the most common cause of upper air-
way obstruction immediately after extubation.4 Stimulation of various sites, from the 
nasal mucosa to the diaphragm, can evoke laryngospasm.5 Smooth extubation requires 
the absence of straining, movement, coughing, breath holding, and laryngospasm.6 
Tracheal intubation and extubation may be associated with hypertension and tachy-
cardia.7 Many techniques and drugs have been proposed to attenuate airway and car-
diovascular responses, but none have been completely successful.8,9
Dexmedetomidine is a highly selective α2-adrenoreceptor agonist that induces se-
dation and analgesia without affecting respiratory status.10,11 Administered after induc-
tion, dexmedetomidine was found to reduce the prevalence of emergence agitation.12 
It has also been reported to reduce arterial blood pressure (BP) and heart rate (HR) 
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dose dependently13 and to decrease the hemodynamic and plasma catecholamine re-
sponses to intubation and extubation in ophthalmic and vascular surgeries.14,15
Fentanyl, a synthetic opioid, has been reported to reduce the prevalence of cough-
ing during and after extubation and to suppress the sneezing reflex after abdomi- 
nal hysterectomy and periocular injections.16,17 Fentanyl has also been reported to at- 
tenuate the cardiovascular responses to tracheal extubation in elective gynecologic 
surgery.18
The aim of this study was to compare the effects of dexmedetomidine and fentanyl 
on airway reflexes and hemodynamic responses to tracheal extubation in patients un-
dergoing rhinoplasty.
PATIENTS AND METHODS
Inclusion and Exclusion Criteria
Study eligibility included patients aged 18 to 60 years who were classified as 
American Society of Anesthesiologists physical status I or II and were undergoing 
elective rhinoplasty between January 2007 and June 2007. Patients with systemic 
illnesses (eg, hypertension [systolic BP (SBP) >160 mm Hg], cardiac disease [conges-
tive heart failure, congenital heart disease, history of myocardial infarction, and ar-
rhythmia], diabetes mellitus, asthma) were excluded.
The study was conducted at the Erciyes University Medical Center, Kayseri, Tur-
key, and was approved by the institutional review board of Erciyes University School 
of Medicine. All study participants provided written informed consent.
Study Design and Procedures
This was a double-blind, randomized, controlled study. Isotonic saline 5 mL/h was 
inserted into an antecubital vein of each patient via a 20-gauge cannula. HR, periph-
eral arterial oxygen saturation by pulse oximetry (SpO2), noninvasive SBP and dia-
stolic BP (DBP), and end-tidal carbon dioxide (ETCO2) were monitored (AS/3 Anes-
thesia Monitor, Datex Engstrom, Helsinki, Finland) throughout the anesthetic period. 
For all patients, anesthesia was induced with thiopental 4 mg/kg IV and fentanyl 
1 μg/kg IV. Vecuronium 0.1 mg/kg IV was used to relax muscles for insertion of the 
endotracheal tube (high-volume/low-pressure endotracheal tubes, Chilecom Medical 
Devices Co., Ltd., Huizhou, People’s Republic of China). The internal diameter of the 
endotracheal tube was 7 to 7.5 mm for women and 8 to 8.5 mm for men. Anesthesia 
was maintained with sevoflurane 1% to 2% in 66% nitrous oxide in oxygen. Patients 
were ventilated to an ETCO2 of 4.2 to 5.5 kPa. No opioids were used after anesthetic 
induction.
Dexmedetomidine* and fentanyl† were prepared in 100 mL of isotonic saline in 
bags that were numbered by the anesthesiologist before the study began. The drugs 
were identical in appearance. The patients were randomized into 2 groups (20 patients 
*Trademark: Precedex® (Hospira, Inc., Lake Forest, Illinois).
†  Trademark: Fentanyl Janssen® (Janssen-Cilag EMEA, Berchem, Belgium).
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per group) via the sealed-envelope method. Before extubation, an anesthesiologist 
who was blinded to treatment administered the study drugs. Extubation quality, 
postoperative sedation, and adverse events were assessed by a different anesthesiologist 
who also was blinded to treatment.
Before extubation, patients received dexmedetomidine 0.5 μg/kg IV over 5 min-
utes (dexmedetomidine group) or fentanyl 1 μg/kg IV over 5 minutes (fentanyl group). 
Sevoflurane and nitrous oxide were discontinued when surgery was complete. A 
residual neuromuscular block was antagonized with neostigmine 0.05 mg/kg and 
atropine 0.02 mg/kg. Oropharyngeal secretions were aspirated before extubation. The 
endotracheal tube was removed smoothly after spontaneous ventilation had returned. 
All patients were extubated by anesthesiologists who were blinded to treatment.
Extubation quality was rated using a 5-point scale: 1 = no coughing; 2 = smooth 
extubation, minimal coughing (1 or 2 times); 3 = moderate coughing (3 or 4 times); 
4 = severe coughing (5–10 times) and straining; and 5 = poor extubation, very un-
comfortable (laryngospasm and coughing >10 times).18 The postoperative sedation 
level was rated using a 3-point scale: 1 = awake, alert; 2 = responds to voice; and 3 = 
not arousable.19 An anesthesiologist who was blinded to treatment assessed all pa-
tients. Breath holding was defined as desaturation and not breathing for ≥20 seconds, 
resulting in a decrease in SpO2 >5% from baseline. HR, SBP, DBP, and SpO2 were 
recorded before anesthesia, after drug administration, after skin incision, at the com-
pletion of surgery, and 1, 5, and 10 minutes before and after tracheal extubation. Any 
laryngospasm, bronchospasm, or desaturation was recorded. 
Extubation time (from end of sevoflurane administration until extubation), dura-
tion of anesthesia, and duration of surgery were noted. Awakening time was assessed 
using the patient’s response to verbal commands. Prompt responses were graded as 
awake and the time from extubation was recorded. Orientation was assessed by the 
patient’s response to questions regarding time, place, and person, and the time from 
extubation was recorded. The concentration of sevoflurane was increased or decreased 
during surgery to maintain BP and HR between 80% and 120% of the preoperative 
values. Hypotension (a decrease in SBP >25% from baseline or an SBP <90 mm Hg) 
was controlled by increasing the fluid infusion rate and decreasing gas concentrations. 
Atropine (0.5-mg IV bolus) was given for bradycardia (HR <45 beats/min). Adverse 
events (eg, bradycardia, hypotension, hypertension, nausea, vomiting, shivering) were 
recorded by a different anesthesiologist who was blinded to treatment. 
Statistical Analysis
The t test was used for between-group comparisons of HR, SBP, DBP, and SpO2. 
Repeated-measures ANOVA was used for within-group comparisons. The χ2 test or 
the Fisher exact test was used to analyze extubation and sedation scores, sex, and ad-
verse events. P < 0.05 was considered statistically significant. 
The primary outcome measure of this study was the effect of dexmedetomidine and 
fentanyl on extubation quality in rhinoplasty. The secondary outcome measures were 
hemodynamic responses to extubation, postoperative sedation scores, extubation time, 
awakening time, orientation time, and prevalence of adverse events.
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RESULTS
Forty patients (25 men, 15 women; mean [SD] age, 24.86 [7.43] years) were included 
in the study. All completed the study with no study protocol violations. Demographic 
data, duration of surgery, and duration of anesthesia were not significantly different be- 
tween the 2 groups (Table I).
There was, however, a significant difference between the groups with respect to 
extubation quality, a primary outcome measure of the study. The prevalence of no 
coughing was significantly higher in patients in the dexmedetomidine group com-
pared with those in the fentanyl group (85% [17] vs 30% [6] of patients, respectively; 
P = 0.001). No patient in the dexmedetomidine group experienced severe coughing, 
whereas 4 patients (20%) in the fentanyl group experienced severe coughing (P = 
0.003). Laryngospasm did not occur in any patient in the dexmedetomidine group, 
whereas it did occur in 1 patient (5%) in the fentanyl group (P = NS) (Table II).
There were no clinically significant decreases in HR, SBP, DBP, or SpO2 after ex-
tubation with dexmedetomidine or fentanyl. There was no significant increase in HR 
after extubation compared with preextubation values in the dexmedetomidine group. 
HR in the fentanyl group was significantly increased at 1, 5, and 10 minutes after 
extubation compared with preextubation (all, P = 0.007). HR was significantly 
higher in the fentanyl group at 1, 5, and 10 minutes after extubation compared with 
the dexmedetomidine group (all, P = 0.003) (Figure 1). The highest HR measured 
after extubation was 136 beats/min in the dexmedetomidine group and 148 beats/min 
in the fentanyl group. Tachycardia (HR >100 beats/min) was observed in 2 patients 
in the dexmedetomidine group and 8 patients in the fentanyl group.
SBP was significantly increased at 1 and 5 minutes after extubation in the dexmede- 
tomidine group (both, P = 0.033) and at 1, 5, and 10 minutes after extubation in 
the fentanyl group (all, P = 0.033) compared with preextubation values. SBP was sig- 
nificantly higher in the fentanyl group compared with the dexmedetomidine group 
10 minutes after extubation (P = 0.037) (Figure 2). The highest SBP measured after 
extubation was 149 mm Hg in the dexmedetomidine group and 158 mm Hg in the 
Table I.  Demographic and clinical characteristics of the study patients (N = 40). Data 
are expressed as mean (SD) unless otherwise specified.
 Dexmedetomidine Group Fentanyl Group 
Characteristic (n = 20) (n = 20) P
Age, y 24.68 (5.78) 25.05 (9.11) 0.833
Sex, no.   0.326
  Male 11 14
  Female 9 6
Height, cm 169.05 (9.30) 171.33 (8.45) 0.441
Weight, kg 64.94 (10.83) 70.17 (8.14) 0.114
Duration of surgery, min 175.57 (53.65) 179.26 (64.24) 0.856
Duration of anesthesia, min 193.21 (53.14) 199.33 (65.94) 0.766
Current Therapeutic Research
214
fentanyl group. SBP >150 mm Hg was observed in 3 patients in the fentanyl group 
and no patients in the dexmedetomidine group.
Compared with preextubation values, DBP did not increase significantly after 
extubation in the dexmedetomidine group. DBP was significantly higher 1 minute 
after extubation in the fentanyl group compared with preextubation (P = 0.033). 
DBP was significantly higher 10 minutes after extubation in the fentanyl group com-
pared with the dexmedetomidine group (P = 0.047) (Figure 2). The highest DBP mea- 
sured after extubation was 91 mm Hg in the dexmedetomidine group and 104 mm Hg 
in the fentanyl group.
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Figure 1.  Mean (SD) heart rate (beats/min) at T1 (before anesthesia), T2 (10 minutes 
before tracheal extubation), T3 (5 minutes before tracheal extubation), T4 (after 
drug administration), T5 (1 minute before tracheal extubation), T6 (1 minute 
after tracheal extubation), T7 (5 minutes after tracheal extubation), and T8 
(10 minutes after tracheal extubation). *P = 0.003 between groups; †P = 0.004 
dexmedetomidine group versus T3; ‡P = 0.007 fentanyl group versus T5.
Table II.  Extubation quality in the dexmedetomidine group and the fentanyl group. Data 
are expressed as no. (%).
 No Minimal Moderate Severe 
Drug Coughing Coughing Coughing Coughing Laryngospasm
Dexmedetomidine  17 (85)* 2 (10) 1 (5) 0† 0
Fentanyl  6 (30) 5 (25)  4 (20) 4 (20) 1 (5)
*P = 0.001 versus fentanyl.
†  P = 0.003 versus fentanyl.
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There were no significant differences in SpO2 between the 2 groups after tracheal 
extubation. Desaturation was not observed in any patient in either group.
There were no significant differences in postoperative sedation scores between the 
2 groups (Table III).
Extubation, awakening, and orientation times were not significantly different be-
tween the 2 groups (Table IV).
Adverse Events
Bradycardia was observed in 4 patients (2 per group), and these patients re-
ceived atropine therapy. Emesis was observed in 2 patients in the dexmedeto- 
midine group. In the fentanyl group, emesis was observed in 3 patients, vomiting 
in 1 patient, and shivering in 1 patient, while vertigo was reported in 1 patient. 
The groups did not differ significantly with regard to the prevalence of adverse 
events.
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Figure 2.  Mean (SD) systolic blood pressure (SBP) and diastolic blood pressure (DBP) at 
T1 (before anesthesia), T2 (10 minutes before tracheal extubation), T3 (5 min-
utes before tracheal extubation), T4 (after drug administration), T5 (1 minute 
before tracheal extubation), T6 (1 minute after tracheal extubation), T7 (5 min- 
utes after tracheal extubation), and T8 (10 minutes after tracheal extubation). 
*P = 0.033 fentanyl group versus T5; †P = 0.033 dexmedetomidine group 
versus T5; ‡P = 0.037 between groups.
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DISCUSSION
Coughing can result in hypertension, tachycardia, increased intraocular and intracra-
nial pressure, myocardial ischemia, bronchospasm, and surgical bleeding.20 Tracheal 
extubation may be followed by several respiratory complications (eg, laryngospasm, 
airway obstruction, desaturation).7 Because the nose is newly reconstructed in rhino-
plasty, ventilation using a face mask can be difficult and might change the shape of 
the nose, requiring ventilation via tracheal intubation. Therefore, coughing, straining, 
and laryngospasm are especially undesirable with this surgery. Subcutaneous emphy-
sema has been reported after rhinoplasty when air was pumped through the lateral 
osteotomy incision during ventilation using a face mask.21 If the trachea can be extu-
bated while the patient is still deeply anesthetized, these prevalences can be alleviat-
ed.6,9 In nonfasting patients or patients who have gastroesophageal reflux disease, this 
technique may not be applicable because of the risk for aspiration.7,9 
In the present study, dexmedetomidine 0.5 μg/kg IV before tracheal extubation was 
associated with significantly less coughing and better quality of extubation than was fen-
tanyl. After an ideal extubation, patients should exhibit adequate ventilatory drive, a 
normal breathing pattern, a patent airway with intact protective reflexes, normal pulmo-
nary function, and the absence of any mechanical perturbation (eg, coughing).22 The pres-
ence of the endotracheal tube leads to reflex responses, the most common of which is 
coughing.23 Kim and Bishop24 reported a 76% prevalence of cough in a study of the effects 
of smoking history and albuterol 200 μg (2 puffs) treatment on the severity and frequency 
of cough during emergence from anesthesia. In the present study, the fentanyl group had 
a similar prevalence of cough (70%), 20% of which was severe. The lower prevalence of 
cough (15%) found with dexmedetomidine compared with fentanyl suggests that dex- 
medetomidine was more effective for improving the quality of extubation.
Table III.  Postoperative sedation scores in patients receiving dexmedetomidine or fen-
tanyl. Data are expressed as no. (%).
  Responds Not 
Variable Awake to Voice Arousable P
Dexmedetomidine  8 (40) 11 (55) 1 (5) 0.267
Fentanyl  12 (60) 6 (30) 2 (10) –
Table IV.  Extubation, awakening, and orientation times in patients who received dexmede- 
tomidine or fentanyl. Data are expressed as mean (SD).
 Dexmedetomidine Fentanyl 
 (n = 20) (n = 20) P
Extubation time, min  7.55 (4.03) 5.61 (3.57) 0.173
Awakening time, min 10.86 (5.40) 10.75 (5.65) 0.957
Orientation time, min 14.66 (6.71) 15.09 (7.75) 0.883
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In a randomized, double-blind, controlled study, Nishina et al18 compared the 
effects of fentanyl 1 and 2 μg/kg IV with those of a control group (placebo) on hemo-
dynamic changes during tracheal extubation and emergence from anesthesia in 
60 patients who underwent elective gynecologic surgery. Although those authors 
recommended the 2-μg/kg dose—because while the number of patients who experi-
enced coughs or strains was similar among the 3 groups, the severity of these symp-
toms was attenuated in the fentanyl group that received the higher dose—they re-
ported that the 1- and 2-μg/kg doses were associated with a significantly reduced HR 
(P < 0.05) but found no significant difference in the prevalence of cough compared 
with placebo. In a randomized, active- and placebo-controlled study, Kong et al25 
investigated whether pretreatment with intravenous narcotics reduced the prevalence 
of adverse effects associated with inhalational desflurane used for anesthetic induction. 
Fentanyl 1 μg/kg (n = 60) and morphine 0.1 mg/kg (n = 60) were associated with a 
decreased prevalence of airway irritation compared with inactive vehicle (isotonic 
saline [n = 60]). The prevalence of cough was significantly lower in the fentanyl 
(5.0%) and morphine (8.3%) groups versus the placebo group (25.0%) (P = 0.002 for 
fentanyl vs placebo; P = 0.013 for morphine vs placebo). The prevalence of apnea was 
13.3% in the fentanyl group, 5.0% in the morphine group, and 20.0% in the placebo 
group (P = 0.012 for morphine vs placebo). Laryngospasm developed in 3.3% and 
1.7% in the fentanyl and morphine groups, respectively, compared with 11.7% in the 
placebo group (P = 0.025 for morphine vs placebo). In the present study, fentanyl 
1 μg/kg was associated with significantly decreased prevalence of hemodynamic effects 
and airway irritation associated with tracheal extubation. Although fentanyl was not 
associated with the prevention of HR increases during extubation, dexmedetomidine 
did appear to prevent HR increases during extubation. There were significantly lower 
increases in HR, SBP, and DBP after extubation in patients who received dexmedetomi-
dine compared with those who received fentanyl. In addition, dexmedetomidine was as- 
sociated with a decrease in the prevalence and severity of cough.
In a randomized, double-blind, placebo-controlled study, Guler et al26 reported 
that dexmedetomidine 0.5 μg/kg was associated with attenuation of both the preva-
lence and severity of airway and circulatory reflexes on emergence from anesthesia in 
intraocular surgery, without prolonged recovery. Cough scores were significantly 
lower in the dexmedetomidine group than in the placebo group (P < 0.05), but there 
were no between-group differences in the prevalences of breath holding and desatura-
tion. HR, SBP, and DBP were significantly increased from baseline at extubation in 
both groups (P < 0.05), but the increase was significantly less substantial with dex-
medetomidine. The time from tracheal extubation to emergence from anesthesia was 
not significantly different between the 2 groups. In the present study, none of the 
patients experienced laryngospasm, and the prevalence of cough was significantly 
lower in patients who received dexmedetomidine before extubation compared with 
those who received fentanyl (P = 0.001). 
In a randomized, placebo-controlled study in patients who underwent elective 
noncardiac surgery, Dyson et al27 assessed the effects of 3 doses of esmolol (1, 1.5, and 
2 mg/kg) on HR and SBP changes during extubation and emergence from anesthesia. 
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Esmolol or inactive vehicle (isotonic saline) was administered intravenously after 
reversal of neuromuscular blockade. No significant increases in HR and SBP were 
reported in the group that received esmolol 2 mg/kg. That same study found that the 
1 mg/kg dose was insufficient to control the increase in SBP. Increases >20% in both 
HR (100% of patients) and SBP (70%) were found in the placebo group. These 
between-group (1 mg/kg vs placebo) differences, however, were not significant. The 
number of patients in whom SBP increased >20% was significantly higher in the 
placebo group than in the esmolol 1.5- and 2-mg/kg groups (P < 0.02). Although the 
primary mechanisms are not clearly understood, tachycardia and hypertension after 
tracheal extubation might be related to changes in catecholamine concentration.28 
In a randomized, double-blind, placebo-controlled study, Talke et al15 compared the 
effects of dexmedetomidine with those of inactive vehicle (isotonic saline) on hemo-
dynamic changes in patients who had undergone vascular surgery. Dexmedeto- 
midine was administered intravenously as follows: 1.2 μg/min from 0 to 20 minutes; 
0.8 μg/min from 20 to 60 minutes; 0.35 μg/min from 60 to 300 minutes; and 
0.15 μg/min from 300 minutes to 48 hours after surgery. That study found that dex-
medetomidine intravenous infusion was associated with significant attenuation of 
increases in HR, BP, and plasma catecholamine concentrations during emergence 
from anesthesia compared with placebo (P < 0.05), although the differences in HR 
and BP were not sustained later in the postoperative period.  
In a randomized, single-blind, placebo-controlled study, Feng et al29 investigated the 
effects of intravenous esmolol, fentanyl, and lidocaine on hemodynamic changes resulting 
from tracheal intubation during the induction of general anesthesia in patients under- 
going elective noncardiac (laryngoscopic) surgery. Esmolol 2 mg/kg was associated with 
significant protection against increased HR and SBP (P < 0.05 for esmolol vs fentanyl, 
lidocaine, and control groups); a low dose (3 μg/kg) of fentanyl was associated with sig-
nificant prevention of hypertension but not tachycardia (P < 0.05 for fentanyl vs control); 
and lidocaine 2 mg/kg did not significantly decrease adverse hemodynamic responses. 
In the present study, although fentanyl was not associated with significant prevention of 
HR increases during extubation, dexmedetomidine was. The increases in HR, SBP, and 
DBP after extubation were significantly lower with dexmedetomidine compared with fen- 
tanyl (P < 0.05). However, although these differences were statistically significant, they 
were probably not clinically significant because of the small difference. 
Limitations
Using fentanyl during the induction of anesthesia might have been a limitation 
of this study, although it has been reported that fentanyl administered during the 
induction of anesthesia does not affect extubation, because rhinoplasty requires 
>3 hours. Additionally, use of fentanyl during anesthesia induction might have 
also been a limitation because of its intraoperative hemodynamic stabilization ef-
fects and its reported ability to reduce intraoperative bleeding in surgical areas 
during rhinoplasty. Another limitation of the present study is that a power analy-
sis was not performed. A final limitation is that the 5-point extubation quality scale 
and the 3-point postoperative sedation scale have not been validated.
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CONCLUSION
The findings of the present study suggest that dexmedetomidine 0.5 μg/kg IV, 
administered before extubation, was more effective in attenuating airway reflex re-
sponses to tracheal extubation and maintaining hemodynamic stability without pro-
longing recovery compared with fentanyl 1 μg/kg IV in these patients undergoing 
rhinoplasty. 
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